Isis Pharmaceuticals hosts Dr. Klaus Parhofer to review KYNAMRO™ data presented at the European Society of Cardiology Congress 2012.
Click here to access a replay of the Webcast that was held on
Wednesday, August 29 at 10:00 a.m. ET
Our pipeline continues to grow with novel therapies in development to treat patients who have significant unmet medical needs.
Learn More